St Petersburg, Florida -- Medical technology group Smith & Nephew has bought privately-held Kalypto Medical Inc., a deal which S&N said adds to its own innovation pipeline in Negative Pressure Wound Therapy (NPWT) as well as to its intellectual property in this area.
Kalypto Medical is the manufacturer of the NPD 1000, a portable, ambulatory NPWT system. Kalypto has invested in NPWT innovation since 2006, said S&N's statement.
"Smith & Nephew entered the NPWT market nearly five years ago with the intent of delivering innovation," commented Robin Carlstein, senior vice president at Smith & Nephew's Advanced Wound Management division.
The acquisition of Kalypto is in line with S&N's strategy to bring more innovation to the market, and further reduce the "human and economic cost of wounds," by directly impacting the health and economic costs that affect customers.
Smith & Nephew did not disclose the terms of this transaction.
NWPT methods use foam and gauze dressing kits, often based on polyurethane foam.